Chris Haskins

Indiana University, Bloomington, Bloomington, IN, United States 
"Chris Haskins"
Mean distance: 106866 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Henderson-Redmond AN, Nealon CM, Davis BJ, et al. (2019) c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner. Neuropharmacology. 107847
Marcus DJ, Zee ML, Davis BJ, et al. (2016) Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic. Plos One. 11: e0160462
Wu CS, Morgan D, Jew CP, et al. (2014) Long-term consequences of perinatal fatty acid amino hydrolase inhibition. British Journal of Pharmacology. 171: 1420-34
Atwood BK, Wager-Miller J, Haskins C, et al. (2012) Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands. Molecular Pharmacology. 81: 250-63
See more...